A detailed history of Pathstone Family Office, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 21,605 shares of BLFS stock, worth $561,946. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,605
Previous 20,767 4.04%
Holding current value
$561,946
Previous $458,000 34.93%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$10.81 - $22.96 $9,058 - $19,240
838 Added 4.04%
21,605 $298,000
Q2 2023

Jan 12, 2024

SELL
$17.19 - $24.34 $14,405 - $20,396
-838 Reduced 3.88%
20,767 $458,000
Q1 2023

May 15, 2023

BUY
$17.67 - $26.07 $366,952 - $541,395
20,767 New
20,767 $451,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.11B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.